Looking to publish in JAIDS Journal of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginJAIDS Journal of Acquired Immune Deficiency Syndromes is a journal focused on HIV/AIDS and related research. It publishes 12 issues per year and lists an Impact Factor of 2.2. The journal highlights clinical science, epidemiology, prevention research, implementation science, critical reviews, letters to the editor, and supplements, and it offers an open access publishing option.
Looking to publish in JAIDS Journal of Acquired Immune Deficiency Syndromes? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
JAIDS Journal of Acquired Immune Deficiency Syndromes accepts the following article types. Click on an article type to view submission instructions.
Basic Science
Clinical Science
Translational Research
Epidemiology
Implementation Science
Prevention Research
Critical Review
Original Articles
Rapid Communications
Brief Reports
Letters To The Editor
Recent Publications
Brief Report: Prognostic Value of Kaposi Sarcoma Herpes Virus–Associated Clinical Symptom Scores in HIV-Associated Kaposi Sarcoma
Maganizo B. Chagomerana, Kelvin R. Mubiru, Scott V. Adams, Carlee B. Moser, Minhee Kang, Triin Umbleja, Michael D. Hughes, Thomas B. Campbell, Margaret Z. Borok, Wadzanai Samaneka, McNeil Ngongondo, Mulinda Nyirenda, Deborah C. Langat, Brenda Hoagland, Aggrey Bukuru, Henriette Burger, John MacRae, Naftali Busakhala, Evangeline Njiru, Noluthando Mwelase, Rosie Mngqbisa, Mina C. Hosseinipour, Susan E. Krown, Thomas S. Uldrick
Exposure to the #ShesWell campaign and Black women’s awareness and knowledge of PrEP
Nivedita L. Bhushan, Stefanie E. Anderson, Vanessa Boudewyns, Ryan S. Paquin, Revae S. Downey, Hannah Getachew-Smith, Jo Ellen Stryker, Jennifer D. Uhrig
Retention in HIV Oral and Injectable HIV Pre-exposure Prophylaxis (PrEP) Care in Milan, Italy
Angelo Roberto Raccagni, Antonio Tiani, Nicolò Capra, Riccardo Lolatto, Gabriele Loi, Elena Bruzzesi, Camilla Muccini, Chiara Maci, Caterina Candela, Antonella Castagna, Silvia Nozza
Development and Internal Validation of a Prediction Model for Reversible Cognitive Frailty in People Living with HIV
Henry Ukachukwu Michael, Marie-Josée Brouillette, Robyn Tamblyn, Lesley K. Fellows, Nancy E. Mayo
Best-Worst Scaling of Patient Preferences for Public Funding for HIV: Spend Less on Medication and More on Economic Support
Matthew R. Golden, Shiven Bhardwaj, Katherine Holzhauer, Shireesha Dhanireddy, Julie C. Dombrowski, Jehan Budak, Monisha Sharma
Frequently asked questions
How long does it take to publish?
Rapid Communications will normally be published within 8 weeks of acceptance. The editorial office will acknowledge receipt of the manuscript via e-mail. Authors reviewing Rapid Communications proofs are expected to return corrections within 24 hours of receipt.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite PremiumIs a cover letter required?
A cover letter is requested for Rapid Communications to explain why the paper merits special attention.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite PremiumWhat are the publication costs?
Hybrid open access is available with an APC charged on acceptance and payable within 30 days. Eligible corresponding authors at participating institutions may receive a $0.00 APC under read-and-publish agreements.
Reformat to JAIDS Journal of Acquired Immune Deficiency Syndromes using Livewrite Premium